Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 9, 1997, Pages 1124-1132

  Stubhaug, A ^a,c   Breivik, H ^a   Eide, P K ^b   Kreunen, M ^a   Foss, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Ketamine; Morphine; NMDA receptor antagonist; Patient controlled analgesia; Postoperative hyperalgesia; Postoperative pain

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG THERAPY; ETIOLOGY; HUMAN; HYPERALGESIA; INCISION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DONOR; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; SPINAL CORD; SPINAL CORD DORSAL HORN; TISSUE INJURY;

EID: 0030661767     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04854.x     Document Type: Article

References (36)

1. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence. Pain 1993: 52: 259-285.
2. Woolf CJ, Wall PD. The relative effectiveness of C primary afferent fibres of different origin in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci 1986: 6: 1433-1443.
3. Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res 1987: 24: 402-406.
4. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987: 26: 1235-1238.
5. Woolf CJ, King AK. Dynamic alterations in the cutaneous mechanosensitive receptive fields of dorsal horn neurons in the rat spinal cord. J Neurosci 1990: 10: 2717-2726.
6. Woolf CJ, Chong M. Pre-emptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993: 77: 362-379.
7. Warncke T, Stubhaug A, Jørum E. Ketamine, an NMDA-receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain (in press).
8. Meyer RA, Campbell JN, Raja SN. Peripheral mechanisms of nociception. In: Wall PD, Melzeck R, eds. Textbook of Pain. New York: Churchill Livingstone Inc, 1994: 13-45.
9. Richmond CE, Bromley LM, Woolf CJ. Preoperative morphine pre-empts postoperative pain. Lancet 1993: 342: 73-75.
10. Collis R, Brandner B, Bromley LM, Woolf CJ. Is there any clinical advantage of increasing the pre-emptive dose of morphine or combining pre-incisional with postoperative morphine administration? Br J Anaesth 1995: 74: 396-399.
11. Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991: 44: 293-299.
12. Eide PK, Jørum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double blind, cross-over comparison with morphine and placebo. Pain 1994: 158: 347-354.
13. Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 1992: 573: 321-323.
14. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983: 79: 565-575.
15. Church J, Lodge D. N-methyl-D-aspartate (NMDA) antagonism is central to the actions of ketamine and other phencyclidine receptor ligands. In: Domino EF, ed. Status of ketamine in anesthesiology. Ann Arbor: NPP Books, 1990: 501-519.
16. Øye I, Hustveit O, Maurset A et al. The chiral forms of ketamine as probes for NMDA receptor function in humans. In: Kameyama T, Nabeshima T, Domino EF, eds. Receptor related agents: biochemistry, pharmacology and behavior. Ann Arbor: NPP Books, 1991: 381-389.
17. Meinert CL. Clinical trials: Design, conduct and analysis. New York: Oxford University Press, 1986: 97.
18. Tigerstedt I, Tammisto T. A modified visual analogue scale (VAS) for evaluation of pain intensity during the immediate postoperative recovery. Schmerz/Pain/Doleur 1988: 9: 27-31.
19. Eide PK, Stubhaug A, Øye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995: 61: 221-228.
20. Tverskoy M, Oz Y, Isakson A, Finger J, Bradley EL, Kissin I. Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Anesth Analg 1994: 78:205-209.
21. Stubhaug A, Breivik H. Post-operative analgesic trials: some important issues. Bailliére's Clinical Anaesthesiology 1995: 9: 555-584.
22. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P Zbinden AM. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg 1995: 81: 63-68.
23. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995: 162: 259-274.
24. Ghoneim MM, Hinrichs JV, Mewaldt SP, Petersen RC. Ketamine: Behavioral effects of subanesthetic doses. J Clin Psychopharmacol 1985: 5: 70-77.
25. Øye I, Paulsen O, Maurset A. Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 1992: 260: 1209-1213.
26. Grant IS, Nimmo WS, Clements JA. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth 1981: 53: 805-810.
27. Breivik H, Breivik EK, Stubhaug A. Clinical aspects of preemptive analgesia: prevention of post-operative pain by pretreatment and continued optimal treatment. Pain Reviews 1996: 3: 63-78.
28. Roytblat L, Korotkoruchko A, Katz J, Glazer M, Greemberg L, Fisher A. Postoperative pain: The effect of low-dose ketamine in addition to general anesthesia. Anesth Analg 1993: 77: 1161-1165.
29. Cherry DA, Plummer JL, Gourlay GK, Coates KR, Odgers CL. Ketamine as an adjunct to morphine in the treatment of pain. Pain 1995: 62: 119-121.
30. Javery KB, Ussery TW, Steger HG, Colclough GW. Comparison of morphine and morphine with ketamine for postoperative analgesia. Can J Anaesth 1996: 13: 212-215.
31. Muller A, Lemos D. Douleurs cancereuses: effet benefique de l'adjonction de ketamine au melange morphine-clonidine-lidocaine administre par vole intrathecale. Ann Fr Aneaesth Reanim 1996: 15: 271-276.
32. Yang CY, Wong CS, Chang JY, Ho ST. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 1996: 3: 379-383.
33. Dubner R, Basbaum AI. Spinal dorsal horn plasticity following tissue or nerve injury. In: Wall PD, Melzack RM eds. Textbook of pain. Edinburgh: Churchill Livingstone, 1994: 225-241.
34. Eide PK, Stubhaug A, Øye I. The NMDA-antagonist ketamine for prevention and treatment of acute and chronic post-operative pain. Bailliére's Clinical Anaesthesiology 1995: 9: 539-554.
35. Kalso E, Perttunen K, Kaasinen S. Pain after thoracic surgery. Acta Anaesthesiol Scand 1992: 36: 96-100.
36. Dajczman E, Gordon A, Kreisman H, Wolkove N. Long-term postthoracotomy pain. Chest 1991: 99: 270-274.